Evidence map›Paper›PMID 36168799›Full record

ArticleClinical nephrology2022

Echocardiographic changes after arteriovenous fistula creation in hemodialysis patients.

Karen Manzur-Pineda, Laisel Martinez, Roger Alvarez, Adriana Dejman, Roberto I Vazquez-Padron, Marwan Tabbara, Juan C Duque

Abstract read
In one paragraph

Article in Clinical nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karen Manzur-Pineda
Laisel Martinez
Roger Alvarez
Adriana Dejman
Roberto I Vazquez-Padron
Marwan Tabbara
Juan C Duque

Funding

Dual Role of Lysyl Oxidase in Arteriovenous Fistula FailureR01DK121227 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHIU, YAN-TING E., VAZQUEZ PADRON, ROBERTO IRENARDO · 2019 to 2023
$2.1M
Vascular Progenitor Cells in Arteriovenous Fistula StenosisR01DK098511 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ANDREOPOULOS, FOTIOS MATTHAIOS, SALMAN, LOAY HATEM · 2013 to 2016
$1.5M
Cellular Mechanisms of Mac-1 Mediated AtheroprotectionK08HL151747 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MARTINEZ, LAISEL · 2020 to 2024
$575k
The Multiple Roles of Lysyl Oxidase in Arteriovenous Fistula FailureI01BX004658 · VA · MIAMI VA HEALTH CARE SYSTEM · PI VAZQUEZ PADRON, ROBERTO IRENARDO · 2020 to 2023
–
BLRD VA I01 BX004658NHLBI NIH HHS K08 HL151747NIDDK NIH HHS R01 DK098511NIDDK NIH HHS R01 DK121227
6 · The paper itself

Abstract

backgroundPulmonary hypertension (PH) is common in end-stage renal disease (ESRD) patients and is associated with increased all-cause and cardiovascular mortality in this group. There is scarce data on the long-term effect of arteriovenous fistula (AVF) creation on pulmonary hypertension (PH) and the reflected changes in echocardiographic measurements. MATERIALS AND

methodsThis is a retrospective study of 54 patients who underwent AVF creation between 2009 and 2014 and with echocardiographic evaluations before and after surgery. We analyzed pairwise changes in right ventricular systolic pressure (RVSP), right atrial pressure (RAP) during systole, left ventricular mass (LVM), tricuspid regurgitation (TR), mitral E/E' ratio, and ejection fraction (EF), as well as the factors that predicted change in RVSP after surgery.

resultsThe median time for the preoperative echocardiogram was 0.3 years (interquartile range (IQR) 0.2 - 0.7 years) prior to AVF creation, while the follow-up echo was done 1.3 (0.6 - 2.1) years after surgery. 67% of the patients had RVSP > 37 mmHg at baseline. There was a significant reduction in RVSP after AVF creation compared to baseline (median 33 (IQR 26 - 43) vs. 46 mmHg, p = 0.0015), with 59% of the patients experiencing a decrease and 19% remaining stable. There were also significant decreases in LVM (201 (143 - 256) vs. 215 (163 - 276), p = 0.045) and RAP systole (10 (10 - 15) vs. 3 (3 - 8); p < 0.001) after surgery. Higher preoperative weight (p = 0.038) and RVSP (p = 0.006), and use of loop diuretics (p = 0.015) were significantly associated with improvement in RVSP after AVF creation.

conclusionOur results suggest that AVF creation is associated with a significant reduction or stable measurements of RVSP in the ESRD population, likely due to an improvement in volume status.

Indexed as

Arteriovenous FistulaHypertension, PulmonaryKidney Failure, ChronicEchocardiographyHumansRenal DialysisRetrospective StudiesSodium Potassium Chloride Symporter InhibitorsSodium Potassium Chloride Symporter Inhibitors

Identifiers

PMID36168799
PMCPMC9990444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.